Nozawa, Masahiro
310  results:
Search for persons X
?
2

Real‐world outcomes of avelumab plus axitinib as first‐line..:

Kato, Taigo ; Nakano, Yuzo ; Hongo, Fumiya...
International Journal of Urology.  31 (2023)  3 - p. 265-272 , 2023
 
?
3

Real‐world effectiveness of nivolumab and subsequent therap..:

Yonese, Junji ; Hinata, Nobuyuki ; Masui, Satoru...
International Journal of Urology.  30 (2023)  9 - p. 762-771 , 2023
 
?
4

Final efficacy and safety results and biomarker analysis of..:

Nakaigawa, Noboru ; Tomita, Yoshihiko ; Tamada, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  3 - p. 416-426 , 2023
 
?
 
?
7

Clinical factors for tumor response, progression, and survi..:

Blas, Leandro ; Shiota, Masaki ; Miyake, Hideaki...
International Journal of Urology.  30 (2023)  9 - p. 788-796 , 2023
 
?
 
?
13

Prognostic value of PD-L1 expression in recurrent renal cel..:

Tamada, Satoshi ; Nozawa, Masahiro ; Ohba, Kojiro...
International Journal of Clinical Oncology.  28 (2022)  2 - p. 289-298 , 2022
 
1-15